Novartis looks to next decade with Biocon biosimilar pact
Novartis and Biocon have teamed up to replenish their pipelines through the development and manufacture of third wave biosimilars.
Novartis and Biocon have teamed up to replenish their pipelines through the development and manufacture of third wave biosimilars.
Cellular Biomedicine Group Inc (CBMG) has selected GE Healthcare’s FlexFactory technology for its CAR-T therapy production facility in Shanghai, China.
AbbVie says it will expand its biomanufacturing site in Ballytivnan, Sligo to support its oncology pipeline.
Novartis will install Berkeley Lights’ Beacon antibody discovery technology, the sixth large pharmaceutical firm to adopt the platform in less than a year.